28 results on '"Wulff-Burchfield, Elizabeth Marie"'
Search Results
2. Updated follow up of a randomized, double-blinded phase II study of ketoconazole (keto), hydrocortisone (HC), and anti-PSMA antibody J591 labeled with 177Lu or 111In in patients (pts) with high-risk non-metastatic (met) castration-resistant prostate...
3. A qualitative evaluation of a nurse-led pre-operative stoma education program for bladder cancer patients
4. Elevating the patient voice: Understanding treatment preferences in patients with advanced prostate cancer.
5. Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).
6. PSA flare in patients with metastatic castration-resistant prostate cancer undergoing 177 Lu-PSMA treatment.
7. Preliminary analysis of baseline characteristics, patient reported outcomes (PROs), and treatment selection in ODYSSEY.
8. Outcomes Database to Prospectively Assess the Changing Therapy Landscape in Renal Cell Carcinoma (ODYSSEY RCC).
9. A pilot study of tazemetostat and pembrolizumab in advanced urothelial carcinoma (ETCTN 10183).
10. Randomized, double-blinded phase II study of ketoconazole (keto), hydrocortisone (HC), and anti-PSMA antibody J591 labeled with 177Lu or 111In in patients (pts) with high-risk non-metastatic (met) castration-resistant prostate cancer (M0 CRPC).
11. IV vitamin C with chemotherapy for cisplatin ineligible bladder cancer patients (CI-MIBC) first-stage analysis NCT04046094.
12. Bringing experimental therapeutics clinical trials network (ETCTN) to underrepresented population.
13. Fosciclopirox clinical proof of concept in patients with nonmuscle invasive and muscle-invasive bladder cancer.
14. Using tele-mentoring to optimize quality of care and quality of life for patients with renal cell carcinoma (TOQQ-RCC).
15. Racial and ethnic disparities among patients with breast cancer and COVID-19.
16. Prognostic impact of obesity in cancer patients with COVID-19 infection: A systematic review and meta-analysis.
17. Code status and outcomes in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) registry analysis.
18. Nationwide trends in in-patient chemotherapy hospitalizations, cost, and mortality for patients with testicular carcinoma.
19. Treatment response in the intact primary renal mass (P-Rmass) and its relationship to the overall response to treatment in patients with metastatic renal cell carcinoma (mRCC).
20. Evaluation of mood disorders in bladder cancer patients and their primary caregivers.
21. Neoadjuvant cisplatin based therapy in bladder cancer: Is less enough?
22. Safety of inactivated vaccines in patients with genitourinary (GU) malignancies receiving immune checkpoint inhibitors (ICI).
23. Abiraterone acetate in comparison to enzalutamide in African American patients with metastatic castrate-resistant prostate cancer: A single-center retrospective study.
24. Long-term impact of head and neck cancer (HNC) and treatment on financial distress and employment of HNC survivors.
25. Late systemic symptom (SS) frequency in head and neck cancer (HNC) survivors as measured by the Vanderbilt Head and Neck Symptom Survey – General Symptoms Subscale (GSS).
26. CT measurement of prevertebral soft tissue (PVST) and epiglottis as a predictor of swallowing dysfunction in head and neck cancer (HNC).
27. Building a Transplantation Physician Workforce for Growing Need: Recruitment Starts during Residency
28. Randomized, double-blinded phase II study of ketoconazole (keto), hydrocortisone (HC), and anti-PSMA antibody J591 labeled with 177 Lu or 111 In in patients (pts) with high-risk non-metastatic (met) castration-resistant prostate cancer (M0 CRPC).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.